| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/18/2011 | EP2321299A2 Pyridons as pdk1 inhibitors |
| 05/18/2011 | EP2321298A2 Aurora kinase modulators and methods of use |
| 05/18/2011 | EP2321297A1 Piperidinyl gpcr agonists |
| 05/18/2011 | EP2321296A1 Substituted 5-aminopyrazoles and use thereof |
| 05/18/2011 | EP2321295A2 4-(pyridin-4-yl)-1h-[1,3,5]triazin-2-one derivatives as gsk3-beta inhibitors for the treatment of neurodegenerative diseases |
| 05/18/2011 | EP2321286A1 Substituted n-oxide pyrazine derivatives |
| 05/18/2011 | EP2321285A1 Diazepan and piperazine derivatives modulators of chemokine receptors |
| 05/18/2011 | EP2321283A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| 05/18/2011 | EP2321282A1 New benzimidazole derivatives |
| 05/18/2011 | EP2321280A2 Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives |
| 05/18/2011 | EP2321278A2 PYRIDINYL MODULATORS OF y-SECRETASE |
| 05/18/2011 | EP2321274A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
| 05/18/2011 | EP2321011A1 Diaryl compounds and uses thereof |
| 05/18/2011 | EP2158194B1 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 05/18/2011 | EP2099759B1 Antibacterial quinoline derivatives |
| 05/18/2011 | EP2091944B1 Substituted bicyclocarboxyamide compounds |
| 05/18/2011 | EP1943232B1 Squaric acid derivatives as inhibitors of histone deacetylase |
| 05/18/2011 | EP1848709B1 Novel salt form of a dopamine agonist |
| 05/18/2011 | EP1373210B1 Heterocyclic diamide invertebrate pest control agents |
| 05/18/2011 | EP1318140B1 Novel amide derivatives and medicinal use thereof |
| 05/18/2011 | CN1863795B P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 05/18/2011 | CN1760324B Cyclometalated transition metal complex and organic electroluminescent display device using the same |
| 05/18/2011 | CN1720225B N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 05/18/2011 | CN102066455A Polymeric compound containing metal complex residue and element comprising same |
| 05/18/2011 | CN102066372A 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 05/18/2011 | CN102066366A Novel substituted pyridin-2-ones and pyridazin-3-ones |
| 05/18/2011 | CN102066360A Quinoline or isoquinoline substituted P2X7 antagonists |
| 05/18/2011 | CN102066359A Novel heteroaryl carboxamide derivatives |
| 05/18/2011 | CN102066358A CGRP receptor antagonists |
| 05/18/2011 | CN102066357A Indoles as modulators of nicotinic acetylcholin receptor subtype alpha-71 |
| 05/18/2011 | CN102066356A Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7 |
| 05/18/2011 | CN102066355A Method for producing an intermediate product of dabigatran etexilate |
| 05/18/2011 | CN102066354A Novel microbiocides |
| 05/18/2011 | CN102066353A Disubstituted phthalazine Hedgehog pathway antagonists |
| 05/18/2011 | CN102066343A Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators |
| 05/18/2011 | CN102066340A 2, 6-diamino-pyrimidin- 5-yl-carboxamides as SRK or JAK kinases inhibitors |
| 05/18/2011 | CN102066339A 2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors |
| 05/18/2011 | CN102066338A Inhibitors of protein kinases |
| 05/18/2011 | CN102066337A 5-hydroxypyrimidine-4-carboxamide compound |
| 05/18/2011 | CN102066335A Substituted pyrimidin-5-carboxamides 281 |
| 05/18/2011 | CN102066334A 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof |
| 05/18/2011 | CN102066333A 5-methyl-1-(naphthalen-2-yl)-1H-pyrazoles useful as sigma receptor inhibitors |
| 05/18/2011 | CN102066326A Pyridone compound |
| 05/18/2011 | CN102066325A Heteroaromatic monoamides as orexinin receptor antagonists |
| 05/18/2011 | CN102066324A Fungicidal pyridines |
| 05/18/2011 | CN102066323A Novel estrogen receptor ligands |
| 05/18/2011 | CN102066322A Compound having NPY Y5 receptor antagonist activity |
| 05/18/2011 | CN102066321A Pyrrolidine derivatives as NK2 receptor antagonists |
| 05/18/2011 | CN102066320A Aryl ketone as MRI |
| 05/18/2011 | CN102060875A Novel quinazoline derivative, and preparation method and application thereof |
| 05/18/2011 | CN102060852A Quinoline complexes, preparation method thereof, quinoline complex-containing catalyst and use of catalyst in catalysis of vinyl polymerization |
| 05/18/2011 | CN102060848A Preparation and application of aromatic amine substituted pyrimidine derivatives |
| 05/18/2011 | CN102060846A Environmentally-friendly quarternary ammonium type cationic active dye and dyeing application thereof |
| 05/18/2011 | CN102060845A Fasudil crystal formation III as well as preparation method and application thereof |
| 05/18/2011 | CN102060844A Fasudil crystal formation IV as well as preparation method and application thereof |
| 05/18/2011 | CN102060843A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 05/18/2011 | CN102060842A 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition |
| 05/18/2011 | CN102060841A Acylhydrazone containing heterocyclic amide structure, oxime ester compound and application thereof |
| 05/18/2011 | CN102060792A 2'-aminochalcone-zole compounds, pyrazoline and cyclopropyl azole derivatives thereof and preparation method and applications of compounds |
| 05/18/2011 | CN102060786A 4-(substituted-1,3-diyne)-4-(trifluoromethyl)-3,4-dihydro substituted quinazoline-2-ketone compound as well as preparation method and application thereof |
| 05/18/2011 | CN102060772A N-(4-substituted phenyl)-1H-3-pyrazolecarboxamide cyclin dependent kinase 2 inhibitors and application thereof |
| 05/18/2011 | CN102060753A Refining method of 4-phenylaminopiperidine analgesic |
| 05/18/2011 | CN101146530B 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 05/18/2011 | CN101052634B Anthranilamide pyridinureas as vegf receptor kinase inhibitors |
| 05/17/2011 | USRE42375 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 05/17/2011 | US7943803 Clathrate compound, method for controlling concentration of aqueous agricultural chemical active ingredient solution, and agricultural chemical formulation |
| 05/17/2011 | US7943768 Piperazine compounds useful as antagonists of C-C chemokines (Ccr2b and CcrS) for the treatment of inflammatory diseases |
| 05/17/2011 | US7943767 Fused bicyclic mTOR inhibitors |
| 05/17/2011 | US7943645 Piperidine compounds for use as orexin receptor antagonist |
| 05/17/2011 | US7943642 Insecticidal N,N-di(heteroarylalkyl)amine derivatives |
| 05/17/2011 | US7943639 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss |
| 05/17/2011 | US7943638 Carboxamide compound and use of the same |
| 05/17/2011 | US7943635 Farnesyl-protein transferase inhibitors |
| 05/17/2011 | US7943627 2,4-diaminopyrimidine derivatives |
| 05/17/2011 | US7943622 Piperazines, pharmaceutical compositions and methods of use thereof |
| 05/17/2011 | US7943614 Carboxamide compound and use of the same |
| 05/17/2011 | US7943605 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/17/2011 | CA2688934C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/17/2011 | CA2514267C Malonamide derivatives as gamma-secretase inhibitors |
| 05/17/2011 | CA2487840C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and their therapeutic application |
| 05/17/2011 | CA2473790C 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 05/17/2011 | CA2470365C 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 05/17/2011 | CA2453418C Variolin derivatives and their use as antitumor agents |
| 05/17/2011 | CA2413945C Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/17/2011 | CA2397194C Alpha v integrin receptor antagonists |
| 05/12/2011 | WO2011057054A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 05/12/2011 | WO2011056652A1 Imidazole derivatives as ido inhibitors |
| 05/12/2011 | WO2011056440A1 Heterocyclic compounds as ccr1 receptor antagonists |
| 05/12/2011 | WO2011055770A1 Fused heterocyclic compound |
| 05/12/2011 | WO2011055303A1 Tablet formulations of neratinib maleate |
| 05/12/2011 | WO2011055270A1 Indole based receptor crth2 antagonists |
| 05/12/2011 | WO2011054848A1 Thetrahydroquinolines derivatives as bromodomain inhibitors |
| 05/12/2011 | WO2011054841A1 Tetrahydroquinoline derivatives and their pharmaceutical use |
| 05/12/2011 | WO2011054773A1 Novel lactam compounds |
| 05/12/2011 | WO2011054433A1 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors |
| 05/12/2011 | WO2010151735A3 4h - pyrido [ 1, 2 - a] pyrimidin - 4 - one derivatives as pi3 k inhibitors |
| 05/12/2011 | WO2010151710A3 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof |
| 05/12/2011 | WO2008079988A9 Quinazolines for pdk1 inhibition |
| 05/12/2011 | US20110112289 Compounds useful as ligands and particularly as organic chromophores for complexing lanthanides and applications thereof |
| 05/12/2011 | US20110112149 Epothilone analogues, their pharmaceutical compositions, their use and their prepa rations |